Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,702,987
-
Number of holders
-
179
-
Total 13F shares, excl. options
-
37,594,851
-
Shares change
-
-579,297
-
Total reported value, excl. options
-
$145,435,659
-
Value change
-
-$6,199,092
-
Put/Call ratio
-
85%
-
Number of buys
-
108
-
Number of sells
-
-71
-
Price
-
$3.87
Significant Holders of Altimmune, Inc. - Common Stock (ALT) as of Q2 2025
244 filings reported holding ALT - Altimmune, Inc. - Common Stock as of Q2 2025.
Altimmune, Inc. - Common Stock (ALT) has 179 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37,594,851 shares
of 80,702,987 outstanding shares and own 47% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (6,372,560 shares), VANGUARD GROUP INC (5,167,124 shares), STATE STREET CORP (2,753,638 shares), TANG CAPITAL MANAGEMENT LLC (2,750,000 shares), GEODE CAPITAL MANAGEMENT, LLC (1,934,880 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1,619,747 shares), Knoll Capital Management, LLC (1,121,524 shares), Caption Management, LLC (980,781 shares), FEDERATED HERMES, INC. (915,458 shares), and UBS Group AG (886,918 shares).
This table shows the top 179 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.